Author:
Sun Qian,Zhang Hongqian,Ding Feng,Zhu Zongwei,Yang Chuanxu
Reference43 articles.
1. In vivo delivery of crispr-cas9 therapeutics: progress and challenges;M Behr;Acta Pharmaceutica Sinica B,2021
2. The next generation of crispr-cas technologies and applications;A Pickar-Oliver;Nature reviews. Molecular cell biology,2019
3. In vivo delivery of crispr-cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia a and b therapy;J P Han;Sci Adv
4. Nanotechnology-based delivery of crispr/cas9 for cancer treatment;X Xu;Adv. Drug Deliver. Rev,2021